Overview

Calyxo (formerly Kalera Medical) is developing a disruptive solution for kidney stone removal that is faster, easier, and better for patients, clinicians and hospitals. Kalera Vacuum Aspiration Catheter (K-VACä) is the only solution that can remove multiple stone fragments in a single insertion, within seconds, and has the potential to deliver unsurpassed stone-free outcome.

The Problem: Presently, stone removal is the most unpredictable and difficult part of ureteroscopy because current tools, i.e. baskets, have serious limitations. The current stone removal devices are extremely time-consuming to use and often extend surgical time, while failing to deliver the desired efficacy. There is a clear unmet medical need for improved solutions and K-VAC is designed to deliver unparalleled stone-free outcome for the patients.

The Solution: Calyxo’s K-VAC has been specifically developed to deliver a highly efficient and complete stone removal in a simple, intuitive procedure. K-VAC has demonstrated highly predictable, outstanding efficacy within seconds, a clinical outcome that cannot be achieved with currently available devices.

Market Opportunity: Approximately 10% of the US population experience kidney stone disease during their lifetime, leading to more than $10 billion a year in treatment costs. The incidence of the kidney stone increases with age and is associated with a high rate of recurrence – a 50% recurrence within 5 years. Ureteroscopy is today’s gold standard procedure in kidney stone treatment and accounts for 60% to 70% of all kidney stone removal procedures. There are an estimated 1.5 million procedures worldwide and over 406,000 procedures annually in the U.S. alone.

Calyxo

Company details are restricted to VIN members. Become a member to view company details.

Thank you for your investment interest. A VIC Investor Network representative will contact you within 5 business days with additional information regarding investment in the company you have selected.